7. 2026 Amendment to the Narcotics Act: Which Cannabinoids Are on the Chopping Block and What Will Remain Legal

The 7th amendment to the NpSG is already casting a shadow. The next round of changes to German cannabinoid law is expected in the fall of 2026, and the entire scene is currently preoccupied with the question of which substances will end up on the list this time. Anyone who uses 9H-HHC, PHC, or an LSD derivative wants to know if that will soon be a thing of the past. That is precisely why we are providing a clear overview here: what has been banned so far, which cannabinoids are being considered as candidates for the 7th NpSG amendment, and what remains legal as things stand. Important to note upfront: much of this is an assessment, not an official decision. All products mentioned are flavoring products and are not intended for consumption.

Key Points

• The 7th NpSG Amendment Ordinance is expected in the fall of 2026. As of June 2026, it has not been officially confirmed which specific substances will be affected.
• Within the industry, 9H-HHC, PHC, and 1FE-LSD are widely considered to be the top candidates for a ban (assessment, no decision has been made).
• Substances that are already banned include 10-OH-HHC, 10-OH-HHCP, 3,4-ETMC, NB-DMT, 1S-LSD, and 1SB-LSD.
• Non-psychoactive cannabinoids such as CBD, CBG-9, and CBN are considered relatively safe.
• THCA is still being traded, but under the expanded definition, it is now subject to closer scrutiny.
• Our advice: Stay informed, choose reputable providers, and check the legal situation before making any purchase.

What is the NpSG, and why is it constantly changing?

The New Psychoactive Substances Act (NpSG) is Germany’s tool for combating the rapidly evolving market for new cannabinoids and research chemicals. Rather than banning each substance individually, it works with substance groups and structural definitions. If a new molecule emerges that fits into a listed group, it can be added through an amendment to the regulation.

That’s exactly what explains the rapid pace of change. Manufacturers are constantly developing new products, and lawmakers respond with the next regulation. It’s a cat-and-mouse game that keeps the market in a state of constant flux. For you, this means that what’s on the shelf today could be gone by the time the next regulation takes effect. You can find a comprehensive overview of the current situation in our Cannabinoid Legal Guide.

It is important to understand the logic behind the structural definitions. The NpSG prohibits not just a single substance, but often an entire family of chemically related molecules. If a cannabinoid is banned, its close relatives automatically come under scrutiny because they have a similar structural composition. That is why, following a ban, it is often possible to predict which substance might be next. Those who recognize the pattern will no longer be caught off guard by any regulation.

Why does the market shift every six months?

The German cannabinoid market operates differently from traditional product markets. As soon as a popular substance is banned, a gap emerges, and it is quickly filled by the next, as-yet-unregulated derivative. It is precisely this mechanism that is driving the rapid development. HHC was followed by a whole wave of successors, and 10-OH-HHC was followed by yet more new variants.

For you as a user, this has two sides. On the one hand, there are always new, legal options to discover. On the other hand, it means that no “gray-area” cannabinoid comes with a permanent guarantee. This dynamic isn’t a cause for concern; it’s simply the nature of this young market. Those who accept it can approach it with ease and make informed choices rather than being caught off guard.

Review: What the NpSG amendments to date have prohibited

To understand the 7th amendment, it’s worth taking a look back. The latest developments have significantly shaken up the market.

The 6th Amendment to the Narcotics Act has removed a whole range of popular substances, including 10-OH-HHC and 10-OH-HHCP, as well as 3,4-ETMC, NB-DMT, and the LSD derivatives 1S-LSD and 1SB-LSD. If you want to know more about the most prominent of these bans, you can find the classification in our article on the 10-OH-HHC ban.

The most recent amendment in April 2026 further expanded the definition of cannabimimetics, which indirectly brings THCA into focus as well. Full details can be found in our article on the 2026 NpSG amendment. The pattern is clear: with each round, the net is tightening, and structurally related successors are coming under scrutiny more quickly.

The 7th Amendment to the NpSG in 2026: What to Expect

Now, let’s get to the main topic. The 7th NpSG Amendment Ordinance is expected in the fall of 2026. As of June 2026, there has been no official confirmation of which specific substances will be included on the list. What is currently circulating is an industry assessment, not an official announcement. That is exactly how you should view the following table: as a guide to risk, not as the actual text of the law.

Why 9H-HHC and PHC in particular? Both are psychoactive and structurally related to substances that are already banned. Based on past trends, it is precisely this combination that makes them likely candidates for regulation. 1FE-LSD is also under scrutiny following the ban on 1S-LSD, as LSD derivatives are being targeted one by one. Ultimately, it is up to the regulators to decide whether this will actually happen. You can read more about this specific case in our overview on whether 9H-HHC is legal.

What is likely to remain legal?

Now for the good news. Not everything is on the line. A whole group of cannabinoids is considered to be significantly less risky, and the common factor is simple: they are not psychoactive.

CBD is the classic cannabinoid and the most extensively studied one of all. It is non-psychoactive, well-established, and considered legally straightforward. CBN is in the same league and is primarily marketed in the context of relaxation and evening use. Neither is typically covered by the NpSG.

CBG-9 is the most promising option in this safe category. It is non-psychoactive, is considered one of the most legally sound new cannabinoids, and is unlikely to be banned. For those seeking a legal basis that is likely to remain valid even after the 7th amendment to the Narcotics Act, CBG-9 is a strong contender. A detailed analysis can be found in our article on what makes CBG-9 unique.

THCA is a special case. In its raw form, it is not psychoactive and is still sold as a flavoring product. However, the expanded definition of cannabimimetics has brought THCA more into the spotlight, which is why we do not classify it as completely safe. You can read more about the current assessment in our article on the legal status of THCA in Germany.

What you can learn from the bans so far

Each round of the NpSG has set a precedent from which we can draw conclusions for the future. First, psychoactive substances are targeted first, while non-psychoactive ones are usually spared. Second, once a substance is banned, its closest structural analog is often targeted in the next round. Third, there is usually only a short window between the announcement and the law’s entry into force.

This leads to a simple rule of thumb. If you want to stay on top of things, focus on the non-psychoactive group. If you prefer the stronger strains, you should check the status of your favorites regularly and not assume that they’ll always be available. Panic buying or hoarding banned products, on the other hand, is not a good idea, because a ban applies to trade and distribution and creates unnecessary risks.

It’s also interesting to look at the sellers’ side. Reputable shops consistently remove banned substances from their product range and start offering legal alternatives in a timely manner. On the other hand, those who aggressively sell off remaining stock just before a ban takes effect are sending a clear signal. It’s precisely this behavior that helps you determine who you can trust.

What does that mean for you?

No need to panic, but it’s a good reason to stay alert. The key takeaway: The market shifts in a way that’s both predictable and unpredictable, with a new cycle emerging roughly every six months. Those who understand this make better decisions.

If you value maximum planning certainty, it’s worth looking into the non-psychoactive group of compounds centered around CBD, CBN, and CBG-9. If you use the more potent “gray area” cannabinoids, you should be aware that their legal status may change with the 7th amendment to the NpSG. You can find an overview of legal options following the latest bans in our guide to legal HHC alternatives.

What you should always look for: a reputable supplier that carries lab-tested products and provides honest, up-to-date information about the legal status of its products. That is exactly what sets a reliable shop apart from a clearance store that just wants to quickly sell off banned goods. All of our products are flavoring products and are not intended for consumption.

This is how we handle legal matters at Happy Flower

In such a fast-moving market, transparency isn’t just a nice-to-have—it’s a must. We consistently remove banned substances from our active product lineup and honestly classify the status of our products, rather than marketing them as permanently safe when they fall into a gray area. Products that are no longer legally marketable are no longer advertised.

At the same time, we’re actively expanding our selection of legal, non-psychoactive products so that you’ll have a reliable source even after the next regulation takes effect. We continuously update our guides as soon as the legal landscape changes. So here you won’t find yesterday’s information, but an assessment that reflects the current situation. And because quality and transparency go hand in hand, we rely on lab-tested products with clear labeling as flavoring products.

Frequently Asked Questions About the 7th Amendment to the NpSG in 2026

When will the 7th amendment to the NpSG take effect?

It is expected in the fall of 2026. As of June 2026, neither the exact date nor the final list of substances has been officially confirmed. The information provided is based on industry estimates, not an official decision.

Will 9H-HHC and PHC be banned?

Both are considered potential candidates for the 7th amendment to the Narcotics Act because they are psychoactive and structurally related to prohibited substances. However, as of June 2026, no official decision has been made. Currently, neither is prohibited, but they fall into a gray area.

Which cannabinoids are most likely to remain legal?

Non-psychoactive cannabinoids such as CBD, CBN, and CBG-9 are considered the least risky. They are not the primary focus of the NpSG, which is aimed primarily at intoxicating substances.

What was prohibited under the latest amendments to the NpSG?

Most recently, substances such as 10-OH-HHC, 10-OH-HHCP, 3,4-ETMC, NB-DMT, 1S-LSD, and 1SB-LSD were added to the NpSG. The definition of cannabimimetics has also been expanded, which brings THCA more into focus.

What should I consider before making a purchase?

Always check the current legal situation, as it changes quickly, and only buy from reputable sellers offering lab-tested products. All cannabinoid products are sold as flavoring products and are not intended for consumption.

Conclusion

The 7th amendment to the NpSG in the fall of 2026 will once again shake up the market. According to current estimates, 9H-HHC, PHC, and 1FE-LSD are particularly at risk, while non-psychoactive cannabinoids such as CBD, CBN, and CBG-9 are considered safe bets. None of this has been confirmed, so the rule is: stay informed and don’t let a headline throw you off track. If you want to play it safe, stick to the legal, non-psychoactive options. If you use cannabinoids in the gray area, you should keep an eye on their status. We keep our guides up to date so you can always make your decision based on the latest information.